Provided herein are cyclopentathiophene carboxamide derivatives as platelet activating factor receptor (PAFR) antagonists, pharmaceutical compositions, use of such compounds in treating ocular diseases, allergies, and inflammation-related disorders, and processes for preparing such compounds.